12 results on '"Murdock, Benjamin J"'
Search Results
2. Gut microbiome correlates with plasma lipids in amyotrophic lateral sclerosis.
- Author
-
Guo, Kai, Figueroa-Romero, Claudia, Noureldein, Mohamed H, Murdock, Benjamin J, Savelieff, Masha G, Hur, Junguk, Goutman, Stephen A, and Feldman, Eva L
- Subjects
AMYOTROPHIC lateral sclerosis ,BLOOD lipids ,GUT microbiome ,NEURODEGENERATION ,MOTOR neuron diseases - Abstract
Amyotrophic lateral sclerosis (ALS) is a complex, fatal neurodegenerative disease. Disease pathophysiology is incompletely understood but evidence suggests gut dysbiosis occurs in ALS, linked to impaired gastrointestinal integrity, immune system dysregulation and altered metabolism. Gut microbiome and plasma metabolome have been separately investigated in ALS, but little is known about gut microbe-plasma metabolite correlations, which could identify robust disease biomarkers and potentially shed mechanistic insight. Here, gut microbiome changes were longitudinally profiled in ALS and correlated to plasma metabolome. Gut microbial structure at the phylum level differed in ALS versus control participants, with differential abundance of several distinct genera. Unsupervised clustering of microbe and metabolite levels identified modules, which differed significantly in ALS versus control participants. Network analysis found several prominent amplicon sequence variants strongly linked to a group of metabolites, primarily lipids. Similarly, identifying the features that contributed most to case versus control separation pinpointed several bacteria correlated to metabolites, predominantly lipids. Mendelian randomization indicated possible causality from specific lipids related to fatty acid and acylcarnitine metabolism. Overall, the results suggest ALS cases and controls differ in their gut microbiome, which correlates with plasma metabolites, particularly lipids, through specific genera. These findings have the potential to identify robust disease biomarkers and shed mechanistic insight into ALS. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. Correlation of Peripheral Immunity With Rapid Amyotrophic Lateral Sclerosis Progression
- Author
-
Murdock, Benjamin J., Zhou, Tingting, Kashlan, Samy R., Little, Roderick J., Goutman, Stephen A., and Feldman, Eva L.
- Published
- 2017
- Full Text
- View/download PDF
4. cGAS/STING and innate brain inflammation following acute high-fat feeding.
- Author
-
Elzinga, Sarah E., Henn, Rosemary, Murdock, Benjamin J., Kim, Bhumsoo, Hayes, John M., Mendelson, Faye, Webber-Davis, Ian, Teener, Sam, Pacut, Crystal, Lentz, Stephen I., and Feldman, Eva L.
- Subjects
ENCEPHALITIS ,ALZHEIMER'S disease ,HIGH-fat diet ,METABOLIC disorders ,NEURODEGENERATION - Abstract
Obesity, prediabetes, and diabetes are growing in prevalence worldwide. These metabolic disorders are associated with neurodegenerative diseases, particularly Alzheimer’s disease and Alzheimer’s disease related dementias. Innate inflammatory signaling plays a critical role in this association, potentially via the early activation of the cGAS/STING pathway. To determine acute systemic metabolic and inflammatory responses and corresponding changes in the brain, we used a high fat diet fed obese mouse model of prediabetes and cognitive impairment. We observed acute systemic changes in metabolic and inflammatory responses, with impaired glucose tolerance, insulin resistance, and alterations in peripheral immune cell populations. Central inflammatory changes included microglial activation in a pro-inflammatory environment with cGAS/STING activation. Blocking gap junctions in neuron-microglial co-cultures significantly decreased cGAS/STING activation. Collectively these studies suggest a role for early activation of the innate immune system both peripherally and centrally with potential inflammatory crosstalk between neurons and glia. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
5. Tofacitinib Suppresses Natural Killer Cells In Vitro and In Vivo : Implications for Amyotrophic Lateral Sclerosis.
- Author
-
Figueroa-Romero, Claudia, Monteagudo, Alina, Murdock, Benjamin J., Famie, Joshua P., Webber-Davis, Ian F., Piecuch, Caroline E., Teener, Samuel J., Pacut, Crystal, Goutman, Stephen A., and Feldman, Eva L.
- Subjects
KILLER cells ,AMYOTROPHIC lateral sclerosis ,CELL-mediated cytotoxicity ,CELL physiology ,IMMUNE system - Abstract
Amyotrophic lateral sclerosis (ALS) is a fatal and incurable neurodegenerative disease with few therapeutic options. However, the immune system, including natural killer (NK) cells, is linked to ALS progression and may constitute a viable therapeutic ALS target. Tofacitinib is an FDA-approved immunomodulating small molecule which suppresses immune cell function by blocking proinflammatory cytokine signaling. This includes the cytokine IL-15 which is the primary cytokine associated with NK cell function and proliferation. However, the impact of tofacitinib on NK activation and cytotoxicity has not been thoroughly investigated, particularly in ALS. We therefore tested the ability of tofacitinib to suppress cytotoxicity and cytokine production in an NK cell line and in primary NK cells derived from control and ALS participants. We also investigated whether tofacitinib protected ALS neurons from NK cell cytotoxicity. Finally, we conducted a comprehensive pharmacokinetic study of tofacitinib in mice and tested the feasibility of administration formulated in chow. Success was assessed through the impact of tofacitinib on peripheral NK cell levels in mice. We found tofacitinib suppressed IL-15-induced activation as measured by STAT1 phosphorylation, cytotoxicity, pro-inflammatory gene expression, and pro-inflammatory cytokine secretion in both an NK cell line and primary NK cells. Furthermore, tofacitinib protected ALS neurons from NK cell-mediated cytotoxicity. In mice, we found tofacitinib bioavailability was 37% in both male and female mice; using these data we formulated mouse containing low and high doses of tofacitinib and found that the drug suppressed peripheral NK cell levels in a dose-dependent manner. These results demonstrate that tofacitinib can suppress NK cell function and may be a viable therapeutic strategy for ALS. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
6. PAI-1 promotes the accumulation of exudate macrophages and worsens pulmonary fibrosis following type II alveolar epithelial cell injury
- Author
-
Osterholzer, John J, Christensen, Paul J, Lama, Vibha, Horowitz, Jeffrey C, Hattori, Noboru, Subbotina, Natalya, Cunningham, Andrew, Lin, Yujing, Murdock, Benjamin J, Morey, Roger E, Olszewski, Michal A, Lawrence, Daniel A, Simon, Richard H, and Sisson, Thomas H
- Published
- 2012
- Full Text
- View/download PDF
7. Amyotrophic Lateral Sclerosis Survival Associates With Neutrophils in a Sex-specific Manner.
- Author
-
Murdock, Benjamin J., Goutman, Stephen A., Boss, Jonathan, Kim, Sehee, and Feldman, Eva L.
- Published
- 2021
- Full Text
- View/download PDF
8. Transcriptional networks of progressive diabetic peripheral neuropathy in the db/db mouse model of type 2 diabetes: An inflammatory story.
- Author
-
Hinder, Lucy M., Murdock, Benjamin J., Park, Meeyoung, Bender, Diane E., O'Brien, Phillipe D., Rumora, Amy E., Hur, Junguk, and Feldman, Eva L.
- Subjects
- *
PERIPHERAL neuropathy , *DIABETIC neuropathies , *SCIATIC nerve , *MATRIX metalloproteinases , *DORSAL root ganglia - Abstract
Diabetic peripheral neuropathy is the most common complication of diabetes and a source of considerable morbidity. Numerous molecular pathways are linked to neuropathic progression, but it is unclear whether these pathways are altered throughout the course of disease. Moreover, the methods by which these molecular pathways are analyzed can produce significantly different results; as such it is often unclear whether previously published pathways are viable targets for novel therapeutic approaches. In the current study we examine changes in gene expression patterns in the sciatic nerve (SCN) and dorsal root ganglia (DRG) of db/db diabetic mice at 8, 16, and 24 weeks of age using microarray analysis. Following the collection and verification of gene expression data, we utilized both self-organizing map (SOM) analysis and differentially expressed gene (DEG) analysis to detect pathways that were altered at all time points. Though there was some variability between SOM and DEG analyses, we consistently detected altered immune pathways in both the SCN and DRG over the course of disease. To support these results, we further used multiplex analysis to assess protein changes in the SCN of diabetic mice; we found that multiple immune molecules were upregulated at both early and later stages of disease. In particular, we found that matrix metalloproteinase-12 was highly upregulated in microarray and multiplex data sets suggesting it may play a role in disease progression. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
9. The dual roles of immunity in ALS: Injury overrides protection.
- Author
-
Murdock, Benjamin J., Bender, Diane E., Segal, Benjamin M., and Feldman, Eva L.
- Subjects
- *
IMMUNE response , *AMYOTROPHIC lateral sclerosis , *DISEASE progression , *MOTOR neurons , *CENTRAL nervous system diseases , *PREVENTION - Abstract
Amyotrophic lateral sclerosis (ALS) is a progressive, fatal neurodegenerative disease affecting motor neurons. Disease progression is accompanied by a multi-phased immune response, and recent studies indicate that the immune system is not simply a bystander during disease, but plays an active role in shaping ALS pathology. The role of the immune system during ALS progression is highly complex, however, as it has been found to have a role in both enhancing neurodegeneration as well as protecting the central nervous system. Previous reports have established that the immune response can therefore be separated into two distinct phases: a protective Type 2 response followed by a neurotoxic Type 1 response. This review will address the two phases of the immune response in ALS and describe their roles during disease progression. More importantly, it will also examine the likely sources of immune polarization that are responsible for shifting immunity from the protective T2 phase to the neurotoxic T1 phase. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
10. Early or Late IL-10 Blockade Enhances Th1 and Th17 Effector Responses and Promotes Fungal Clearance in Mice with Cryptococcal Lung Infection.
- Author
-
Murdock, Benjamin J., Teitz-Tennenbaum, Seagal, Gwo-Hsiao Chen, Dils, Anthony J., Malachowski, Antoni N., Curtis, Jeffrey L., Olszewski, Michal A., and Osterholzer, John J.
- Subjects
- *
INTERLEUKIN-10 , *T helper cells , *LUNG infections , *LUNG diseases -- Immunological aspects , *IMMUNOREGULATION , *CRYPTOCOCCUS neoformans - Abstract
The potent immunoregulatory properties of IL-10 can counteract protective immune responses and, thereby, promote persistent infections, as evidenced by studies of cryptococcal lung infection in IL-10-deficient mice. To further investigate how IL-10 impairs fungal clearance, the current study used an established murine model of C57BL/6J mice infected with Cryptococcus neoformans strain 52D. Our results demonstrate that fungal persistence is associated with an early and sustained expression of IL-10 by lung leukocytes. To examine whether IL-10-mediated immune modulation occurs during the early or late phase of infection, assessments of fungal burden and immunophenotyping were performed on mice treated with anti-IL-10R-blocking Ab at 3, 6, and 9 d postinfection (dpi) (early phase) or at 15, 18, and 21 dpi (late phase). We found that both early and late IL-10 blockade significantly improved fungal clearance within the lung compared with isotype control treatment when assessed 35 dpi. Immunophenotyping identified that IL-10 blockade enhanced several critical effector mechanisms, including increased accumulation of CD4+ T cells and B cells, but not CD8+ T cells; specific increases in the total numbers of Th1 and Th17 cells; and increased accumulation and activation of CD11b+ dendritic cells and exudate macrophages. Importantly, IL-10 blockade effectively abrogated dissemination of C. neoformans to the brain. Collectively, this study identifies early and late cellular and molecular mechanisms through which IL-10 impairs fungal clearance and highlights the therapeutic potential of IL-10 blockade in the treatment of fungal lung infections. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
11. Implicating Exudate Macrophages and Ly-6Chigh Monocytes in CCR2-Dependent Lung Fibrosis following Gene-Targeted Alveolar Injury.
- Author
-
Osterholzer, John J., Olszewski, Michal A., Murdock, Benjamin J., Gwo-Hsiao Chen, Erb-Downward, John R., Subbotina, Natalya, Browning, Keely, Yujing Lin, Morey, Roger E., Dayrit, Jeremy K., Horowitz, Jeffrey C., Simon, Richard H., and Sisson, Thomas H.
- Subjects
- *
PULMONARY fibrosis , *MONOCYTES , *CHEMOKINE receptors , *PULMONARY alveoli , *ALVEOLAR macrophages , *TRANSFORMING growth factors-beta , *INTERLEUKIN-13 , *CD antigens , *WOUNDS & injuries - Abstract
The alveolar epithelium is characteristically abnormal in fibrotic lung disease, and we recently established a direct link between injury to the type II alveolar epithelial cell (AEC) and the accumulation of interstitial collagen. The mechanisms by which damage to the epithelium induces lung scarring remain poorly understood. It is particularly controversial whether an insult to the type II AEC initiates an inflammatory response that is required for the development of fibrosis. To explore whether local inflammation occurs following a targeted epithelial insult and contributes to lung fibrosis, we administered diphtheria toxin to transgenic mice with type II AEC-restricted expression of the diphtheria toxin receptor. We used immunophenotyping techniques and diphtheria toxin receptor-expressing, chemokine receptor-2-deficient (CCR2-/-) mice to determine the participation of lung leukocyte subsets in pulmonary fibrogenesis. Our results demonstrate that targeted type II AEC injury induces an inflammatory response that is enriched for CD11b+ nonresident exudate macrophages (ExM) and their precursors, Ly-6Chigh monocytes. CCR2 deficiency abrogates the accumulation of both cell populations and protects mice from fibrosis, weight loss, and death. Further analyses revealed that the ExM are alternatively activated and that ExM and Ly-6Chigh monocytes express mRNA for IL-13, TGF-β, and the collagen genes, COL1A1 and COLIIIA1. Furthermore, the accumulated ExM and Ly-6Chigh monocytes contain intracellular collagen, as detected by immunostaining. Together, these results implicate CCR2 and the accumulation of ExM and Ly-6Chigh monocytes as critical determinants of pulmonary fibrosis induced by selective type II AEC injury. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
12. Local GM-CSF-Dependent Differentiation and Activation of Pulmonary Dendritic Cells and Macrophages Protect against Progressive Cryptococcal Lung Infection in Mice.
- Author
-
Gwo-Hsiao Chen, Teitz-Tennenbaum, Seagal, Neal, Lori M., Murdock, Benjamin J., Malachowski, Antoni N., Dils, Anthony J., Olszewski, Michal A., and Osterholzer, John J.
- Subjects
- *
CRYPTOCOCCUS neoformans , *DENDRITIC cells , *MACROPHAGES , *LUNG infections , *IMMUNE response , *LEUCOCYTES , *LABORATORY mice - Abstract
Patients with acquired deficiency in GM-CSF are susceptible to infections with Cryptococcus neoformans and other opportunistic fungi. We previously showed that GM-CSF protects against progressive fungal disease using a murine model of cryptococcal lung infection. To better understand the cellular and molecular mechanisms through which GM-CSF enhances antifungal host defenses, we investigated temporal and spatial relationships between myeloid and lymphoid immune responses in wild-type C57BL/6 mice capable of producing GM-CSF and GM-CSF-deficient mice infected with a moderately virulent encapsulated strain of C. neoformans (strain 52D). Our data demonstrate that GM-CSF deficiency led to a reduction in: 1) total lung leukocyte recruitment; 2) Th2 and Thl7 responses; 3) total numbers of CDllb+ dendritic cells (DC) and CDllb- and CDllb+ macrophages (MΦ); 4) DC and MΦ activation; and 5) localization of DC and MΦ to the microanatomic sites of alveolar infection. In contrast, GM-CSF deficiency resulted in increased accumulation of DC and MΦ precursors, namely Ly-6Chigh monocytes, in the blood and lungs of infected mice. Collectively, these results show that GM-CSF promotes the local differentiation, accumulation, activation, and alveolar localization of lung DC and MΦ in mice with cryptococcal lung infection. These findings identify GM-CSF as central to the protective immune response that prevents progressive fungal disease and thus shed new light on the increased susceptibility to these infections observed in patients with acquired GM-CSF deficiency. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.